000			02731nam a22003377a 4500
008			211101s20212021 xxu||||| |||| 00| 0 eng d
022			_a1734-1922
040			_aOvid MEDLINE(R)
099			_a34336017
245			_aLength of stay and readmission in older adults hospitalized for heart failure.
251			_aArchives of Medical Science. 17(4):891-899, 2021.
252			_aArch. Med. Sci.. 17(4):891-899, 2021.
253			_aArchives of medical science : AMS
260			_c2021
260			_fFY2022
265			_sepublish
266			_d2021-11-01
520			_aConclusions: In propensity score-matched balanced cohorts of patients with HF, a longer LoS was independently associated with poor outcomes, which persisted when LoS > 10 days were excluded. Copyright: (c) 2019 Termedia & Banach.
520			_aIntroduction: Hospital length of stay (LoS) and hospital readmissions are metrics of healthcare performance. We examined the association between these two metrics in older patients hospitalized with decompensated heart failure (HF).
520			_aMaterial and methods: Eight thousand and forty-nine patients hospitalized for HF in 106 U.S. hospitals had a median LoS of 5 days; among them, 3777 had a LoS > 5 days. Using propensity scores for LoS > 5 days, we assembled 2723 pairs of patients with LoS 1-5 vs. > 5 days. The matched cohort of 5446 patients was balanced on 40 baseline characteristics. We repeated the above process in 7045 patients after excluding those with LoS > 10 days, thus assembling a second matched cohort of 2399 pairs of patients with LoS 1-5 vs. 6-10 days. Hazard ratios (HR) and 95% confidence intervals (CI) for outcomes associated with longer LoS were estimated in matched cohorts.
520			_aResults: In the primary matched cohort (n = 5446), LoS > 5 days was associated with a higher risk of all-cause readmission at 30 days (HR = 1.16; 95% CI: 1.04-1.31; p = 0.010), but not during longer follow-up. A longer LoS was also associated with a higher risk of mortality during 8.8 years of follow-up (HR = 1.13; 95% CI: 1.06-1.21; p < 0.001). LoS had no association with HF readmission. Similar associations were observed among the matched sensitivity cohort (n = 4798) that excluded patients with LoS > 10 days.
546			_aEnglish
650			_aIN PROCESS -- NOT YET INDEXED
651			_aMedStar Heart & Vascular Institute
657			_aJournal Article
700			_aDooley, Daniel J
700			_aLam, Phillip H
790			_aAhmed A, Allman RM, Aronow WS, Arundel C, Dooley DJ, Faselis C, Fonarow GC, Lam PH, Morgan C, Sheriff HM
856			_uhttps://dx.doi.org/10.5114/aoms.2019.89702 _zhttps://dx.doi.org/10.5114/aoms.2019.89702
942			_cART _dArticle
999			_c6966 _d6966